Hereditary Breast Cancer: The Era of New Susceptibility Genes

Rare Mutations in XRCC2 Increase the Risk of Breast Cancer

(2012) D.J. Park et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

(2012) Florentia Fostira et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families

(2012) D J Osher et al.   BRITISH JOURNAL OF CANCER

Familial Breast Cancer

(2012) F Lalloo et al.   CLINICAL GENETICS

Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations

(2012) SA Narod et al.   CLINICAL GENETICS

Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families

(2012) Irene Catucci et al.   Familial Cancer

Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance

(2012) Irma Kluijt et al.   Familial Cancer

Hereditary ovarian cancer: Beyond the usual suspects

(2012) Kathryn P. Pennington et al.   GYNECOLOGIC ONCOLOGY

Loss of function germline mutations in RAD51D in women with ovarian carcinoma

(2012) Anneka Wickramanyake et al.   GYNECOLOGIC ONCOLOGY

Response to DNA damage of CHEK2 missense mutations in familial breast cancer

(2012) Wendy Roeb et al.   HUMAN MOLECULAR GENETICS

Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families

(2012) Ana Osorio et al.   HUMAN MOLECULAR GENETICS

Rare germline mutations inPALB2and breast cancer risk: A population-based study

(2012) Marc Tischkowitz et al.   HUMAN MUTATION

Rare variants in XRCC2 as breast cancer susceptibility alleles: Table 1

(2012) Florentine S Hilbers et al.   JOURNAL OF MEDICAL GENETICS

A Finnish founder mutation inRAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1

(2012) Liisa M Pelttari et al.   JOURNAL OF MEDICAL GENETICS

Translational advances regarding hereditary breast cancer syndromes

(2012) M. Gage et al.   JOURNAL OF SURGICAL ONCOLOGY

Cancer predisposing BARD1 mutations in breast–ovarian cancer families

(2011) Magdalena Ratajska et al.   BREAST CANCER RESEARCH AND TREATMENT

Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes

(2011) Mireia Menéndez et al.   BREAST CANCER RESEARCH AND TREATMENT

Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer

(2011) S. Casadei et al.   CANCER RESEARCH

RAD51C is a susceptibility gene for ovarian cancer

(2011) Liisa M. Pelttari et al.   HUMAN MOLECULAR GENETICS

CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women

(2011) M. A. Adank et al.   JOURNAL OF MEDICAL GENETICS

A role for XRCC2 gene polymorphisms in breast cancer risk and survival

(2011) W.-Y. Lin et al.   JOURNAL OF MEDICAL GENETICS

Germline mutations in RAD51D confer susceptibility to ovarian cancer

(2011) Chey Loveday et al.   NATURE GENETICS

Mutations in BRIP1 confer high risk of ovarian cancer

(2011) Thorunn Rafnar et al.   NATURE GENETICS

High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations

(2010) M G F van Lier et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Regulation of Homologous Recombination in Eukaryotes

(2010) Wolf-Dietrich Heyer et al.   Annual Review of Genetics

Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2transcripts

(2010) Phillip J Whiley et al.   BMC Medical Genetics

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

(2010) Agnieszka Dansonka-Mieszkowska et al.   BMC Medical Genetics

PALB2 mutations in European familial pancreatic cancer families

(2010) EP Slater et al.   CLINICAL GENETICS

The importance of XRCC2 in RAD51-related DNA damage repair

(2010) Cathryn E. Tambini et al.   DNA REPAIR

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits

(2010) C. R. M. Lammens et al.   Familial Cancer

Peutz-Jeghers syndrome: a systematic review and recommendations for management

(2010) A. D. Beggs et al.   GUT

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

(2010) Xiaohong R. Yang et al.   JNCI-Journal of the National Cancer Institute

Mutation of the RAD51C gene in a Fanconi anemia–like disorder

(2010) Fiona Vaz et al.   NATURE GENETICS

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

(2010) Tom Walsh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2French Canadian families with high risk of breast cancer

(2009) Sylvie Desjardins et al.   BMC CANCER

Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response

(2009) Travis H. Stracker et al.   DNA REPAIR

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

(2009) P Langer et al.   GUT

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families Withp53Germline Mutations

(2009) Kelly D. Gonzalez et al.   JOURNAL OF CLINICAL ONCOLOGY

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

(2009) Gilles Thomas et al.   NATURE GENETICS

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1

(2009) Wei Zheng et al.   NATURE GENETICS

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

(2009) Shahana Ahmed et al.   NATURE GENETICS

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

(2009) S. Jones et al.   SCIENCE

Current Guidelines and Best Practice Evidence for Intensified/Enhanced Breast Cancer Screening in Women with BRCA Mutations

(2009) Cathleen M. Waters et al.   JNP-Journal for Nurse Practitioners

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

(2008) L Mellemkjær et al.   BRITISH JOURNAL OF CANCER

CHEK2*1100delC Genotyping for Clinical Assessment of Breast Cancer Risk: Meta-Analyses of 26,000 Patient Cases and 27,000 Controls

(2008) Maren Weischer et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic Counseling and Testing for Common Hereditary Breast Cancer Syndromes

(2008) Dawn C. Allain   JOURNAL OF MOLECULAR DIAGNOSTICS

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene

(2008) Jirina Bartkova et al.   Molecular Oncology